BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 25919529)

  • 1. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance With Preferred Reporting Items for Systematic Review and Meta-Analysis Individual Participant Data Statement for Meta-Analyses Published for Stroke Studies.
    Jumah F; Chotai S; Ashraf O; Rallo MS; Raju B; Gadhiya A; Sun H; Narayan V; Gupta G; Nanda A
    Stroke; 2021 Aug; 52(9):2817-2826. PubMed ID: 34082573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann T; Mulrow CD; Shamseer L; Moher D
    J Clin Epidemiol; 2020 Feb; 118():60-68. PubMed ID: 31740319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration.
    Zhang X; Tan R; Lam WC; Cheng CW; Yao L; Wang XQ; Li SY; Aixinjueluo QY; Yang KH; Shang HC; Wu TX; Lyu AP; Bian ZX
    Syst Rev; 2020 Oct; 9(1):247. PubMed ID: 33100229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRISMA harms checklist: improving harms reporting in systematic reviews.
    Zorzela L; Loke YK; Ioannidis JP; Golder S; Santaguida P; Altman DG; Moher D; Vohra S;
    BMJ; 2016 Feb; 352():i157. PubMed ID: 26830668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting quality of systematic reviews with network meta-analyses in Endodontics.
    Nagendrababu V; Narasimhan S; Faggion CM; Dharmarajan L; Jacob PS; Gopinath VK; Dummer PMH
    Clin Oral Investig; 2023 Jul; 27(7):3437-3445. PubMed ID: 36914841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.
    Elsman EBM; Butcher NJ; Mokkink LB; Terwee CB; Tricco A; Gagnier JJ; Aiyegbusi OL; Barnett C; Smith M; Moher D; Offringa M
    Syst Rev; 2022 Jun; 11(1):121. PubMed ID: 35698213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
    J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring reporting quality of systematic reviews and Meta-analyses on nursing interventions in patients with Alzheimer's disease before and after PRISMA introduction.
    Sun X; Zhou X; Yu Y; Liu H
    BMC Med Res Methodol; 2018 Nov; 18(1):154. PubMed ID: 30497417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.